3 results
Approved WMOCompleted
To determine the toxicity of Zirconium-89 (Zr89) labelled Cetuximab in patient with stage IV cancer.
Approved WMORecruiting
The primary objective of this study is to determine the competence of a magnetic marker as a technique to localise non-palpable breast cancer, measured through retrieval rate using only the magnetic probe. The secondary objectives of this study are…
Approved WMORecruiting
Primary objectiveThe primary objectives of this feasibility clinical investigation are to assess the overall usability of the Philips AirWaze investigational device as measured by the System Usability Score (SUS), and the accuracy of the tool-in-…